Guangzhou, China

Chenliang Zhang

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Overseas Pharmaceuticals, Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenliang Zhang. Retrieved from https://idiyas.com/inventor/chenliang-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chenliang Zhang - Innovator in Controlled-Release Tablet Technology

Introduction

Chenliang Zhang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release drug formulations. His innovative work has the potential to enhance the effectiveness of pain management therapies.

Latest Patents

Chenliang Zhang holds a patent for a "Controlled-release tablet of ibuprofen and method for preparing same." This invention features a unique design that includes a drug-containing immediate-release layer and a drug-containing sustained-release layer. The sustained-release layer contains a greater mass of ibuprofen compared to the immediate-release layer, ensuring an effective analgesic effect for up to 24 hours after administration.

Career Highlights

Zhang is currently employed at Overseas Pharmaceuticals, Ltd., where he continues to advance his research in pharmaceutical formulations. His work focuses on improving drug delivery systems to provide better therapeutic outcomes for patients.

Collaborations

Chenliang Zhang collaborates with several talented individuals in his field, including Xiaoguang Wen and Xiaofeng Huang. These partnerships foster innovation and contribute to the development of new pharmaceutical technologies.

Conclusion

Chenliang Zhang's contributions to controlled-release tablet technology exemplify the importance of innovation in the pharmaceutical industry. His work not only enhances pain management but also sets a precedent for future advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…